by EmpathiCSubstanceS | Jul 20, 2018 | Addiction
The psychedelic drug ibogaine is known for two things: its reputation in some circles as a panacea for addiction and the visceral hallucinations it induces. Positive anecdotes abound from people who have sought out the illegal drug at underground clinics. Just one...
by EmpathiCSubstanceS | Jul 20, 2018 | Bipolar Disorder
What would you see if you could look inside a hallucinating brain? Despite decades of scientific investigation, we still lack a clear understanding of how hallucinogenic drugs such as LSD (lysergic acid diethylamide), mescaline, and psilocybin (the main active...
by EmpathiCSubstanceS | Jul 20, 2018 | Depression
The resumption of clinical research with psychedelics is producing preliminary evidence of benefit for a variety of conditions. These include depression, substance abuse and palliative care. Some research also indicates efficacy in attaining quasi-clinical goals such...
by EmpathiCSubstanceS | Jul 20, 2018 | Anxiety
“I’m going to take you on a ride here,” the music seemed to tell a severely depressed patient who had just been given a dose of the “magic mushrooms” active ingredient. “But I won’t abandon you.” The patient was recounting to Dutch postdoctoral neuroscientist Mendel...
by EmpathiCSubstanceS | Jul 20, 2018 | Anxiety
After decades of political suppression, studies on psychedelics are now experiencing what top researchers have dubbed a renaissance. Here are four drugs that made recent breakthroughs in psychedelic science: Psilocybin for end-of-life psychological disorders Two...
